Viatris GX: what changed
What changed
Viatris GX
NACE 46.460, Wholesale of pharmaceutical and medical goods
filed annual accounts (NBB)
Net result for the year
€407,069
2024 · €395,432+€11,637
Equity
€27.9m
2024 · €27.5m+€407,069
Cash
-
not filed
Balance sheet total
€31.1m
2024 · €31.3m-€183,246
Largest movements
Assets
No asset line moved by more than 1% of the balance sheet total.
Equity and liabilities
- Other debts -€520,280
down €520,280 (-14.5%), from €3.6m to €3.1m
- Profit (loss) carried forward +€407,069
up €407,069 (+14.0%), from €2.9m to €3.3m
Income statement
No income-statement line moved by more than 1% of the activity.
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€395,432
Staff costs
-€58
Depreciation
+€6,296
Write-downs
-€1,625
Other operating charges
+€266
Other operating items
+€89,990
Financial income
+€18,705
Financial charges
-€91,668
Taxes
-€10,268
Result 2025
€407,069
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
Cash or the result is not a separate line in both sets of accounts. So the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €31,290,440 | €31,107,194 | -€183,246 | -0.6% |
| Fixed assets | 21/28 | €30,014,371 | €29,993,824 | -€20,547 | -0.1% |
| Intangible fixed assets | 21 | €0 | - | = | |
| Tangible fixed assets | 22/27 | €22,733 | €2,185 | -€20,547 | -90.4% |
| Furniture and vehicles | 24 | €2,793 | €2,185 | -€608 | -21.8% |
| Other tangible fixed assets | 26 | €19,939 | €0 | -€19,939 | -100% |
| Financial fixed assets | 28 | €29,991,639 | €29,991,639 | = | 0.0% |
| Affiliated companies | 280/1 | €29,989,189 | €29,989,189 | = | 0.0% |
| Participating interests | 280 | €29,989,189 | €29,989,189 | = | 0.0% |
| Other financial fixed assets | 284/8 | €2,450 | €2,450 | = | 0.0% |
| Amounts receivable and cash guarantees | 285/8 | €2,450 | €2,450 | = | 0.0% |
| Current assets | 29/58 | €1,276,069 | €1,113,370 | -€162,699 | -12.8% |
| Amounts receivable within one year | 40/41 | €1,276,069 | €1,113,370 | -€162,699 | -12.8% |
| Trade receivables | 40 | €315,941 | €303,245 | -€12,696 | -4.0% |
| Other amounts receivable | 41 | €960,128 | €810,125 | -€150,003 | -15.6% |
| Total equity and liabilities | 10/49 | €31,290,440 | €31,107,194 | -€183,246 | -0.6% |
| Equity | 10/15 | €27,528,395 | €27,935,464 | +€407,069 | +1.5% |
| Contributions | 10/11 | €24,576,264 | €24,576,264 | = | 0.0% |
| Reserves | 13 | €52,175 | €52,175 | = | 0.0% |
| Non-distributable reserves | 130/1 | €52,175 | €52,175 | = | 0.0% |
| Reserves not available under the articles | 1311 | €52,175 | €52,175 | = | 0.0% |
| Profit (loss) carried forward | 14 | €2,899,956 | €3,307,025 | +€407,069 | +14.0% |
| Amounts payable | 17/49 | €3,762,045 | €3,171,730 | -€590,315 | -15.7% |
| Amounts payable within one year | 42/48 | €3,762,045 | €3,171,730 | -€590,315 | -15.7% |
| Trade debts | 44 | €178,289 | €108,255 | -€70,034 | -39.3% |
| Suppliers | 440/4 | €178,289 | €108,255 | -€70,034 | -39.3% |
| Taxes, remuneration and social security | 45 | €0 | €0 | = | |
| Taxes | 450/3 | €0 | €0 | = | |
| Other amounts payable | 47/48 | €3,583,755 | €3,063,475 | -€520,280 | -14.5% |
| Operating income | 70/76A | €1,368,553 | €1,495,248 | +€126,695 | +9.3% |
| Other operating income | 74 | €1,368,553 | €1,495,248 | +€126,695 | +9.3% |
| Operating charges | 60/66A | €797,723 | €829,550 | +€31,827 | +4.0% |
| Goods for resale, raw materials and consumables | 60 | €115 | €0 | -€115 | -100% |
| Purchases | 600/8 | €115 | €0 | -€115 | -100% |
| Services and other goods | 61 | €772,124 | €808,945 | +€36,821 | +4.8% |
| Remuneration, social security and pensions | 62 | €0 | €58 | +€58 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €26,843 | €20,547 | -€6,296 | -23.5% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€1,625 | €0 | +€1,625 | |
| Other operating charges | 640/8 | €266 | €0 | -€266 | -100% |
| Operating profit (loss) | 9901 | €570,830 | €665,698 | +€94,868 | +16.6% |
| Financial income | 75/76B | €1,331 | €20,035 | +€18,705 | +1,405% |
| Recurring financial income | 75 | €1,331 | €19,515 | +€18,185 | +1,366% |
| Income from financial fixed assets | 750 | €1,111 | €18,688 | +€17,577 | +1,582% |
| Other financial income | 752/9 | €220 | €827 | +€608 | +276% |
| Non-recurring financial income | 76B | - | €520 | +€520 | |
| Financial charges | 65/66B | €186,997 | €278,665 | +€91,668 | +49.0% |
| Recurring financial charges | 65 | €186,997 | €116,227 | -€70,770 | -37.8% |
| Debt charges | 650 | €181,346 | €109,680 | -€71,667 | -39.5% |
| Other financial charges | 652/9 | €5,651 | €6,548 | +€897 | +15.9% |
| Non-recurring financial charges | 66B | - | €162,438 | +€162,438 | |
| Profit (loss) for the period before taxes | 9903 | €385,164 | €407,069 | +€21,904 | +5.7% |
| Income taxes | 67/77 | -€10,268 | - | +€10,268 | |
| Taxes | 670/3 | €0 | - | = | |
| Tax adjustments and reversals of tax provisions | 77 | €10,268 | - | -€10,268 | |
| Profit (loss) for the period | 9904 | €395,432 | €407,069 | +€11,637 | +2.9% |
| Profit (loss) for the period to be appropriated | 9905 | €395,432 | €407,069 | +€11,637 | +2.9% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.